Currently, bone marrow and bone fragments containing valuable stem cells are discarded as waste during routine bone operations. The potential of these stem cells lies primarily in their use for
regenerative therapies, such as the treatment of bone fractures.
Our aim is to harvest these stem cells with new instruments and methods and to store them in cross-border biobanks. Thereby, this valuable resource can be made available for therapeutic purposes or for research into advanced therapies.
BONEBANK creates the preconditions for a diverse field of application of stem cells in the process of bone healing:
Clinicians and hospitals
implement the BONEBANK approach to harvest bone marrow stem cells during routine operations.
Public and private biobank operators
are part of the BONEBANK value chain to store and
market stem cells.
use bone marrow stem cells for research purposes.
Life Science Industry (Medtech, Biotech, Pharma)
purchase bone marrow stem cells for research and
the development of therapies.
Politicians and the general public
understand the potentials of bone marrow stem cells for regenerative medicine and the value of the BONEBANK network for the cross-border region.